Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Quebec man seeks bail as 1994 murder conviction likely a miscarriage of justice

December 18, 2025

Bitget lists VOOI (VOOI) for Spot Trading

December 18, 2025

Former Saskatoon principal Duff Friesen gets six-month conditional sentence

December 18, 2025

Faraday Future Plan to Complete FF 91 2.0 Delivery and Transaction Process with ZEVO CEO Hebron Sher on December 22, with a Delivery Ceremony in January 2026

December 18, 2025

Google’s Gemini app can check videos to see if they were made with Google AI

December 18, 2025
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » United States Self-Monitoring Blood Glucose Market Projected to Reach $9.76 Billion by 2028, as Reported in Latest Research
Press Release

United States Self-Monitoring Blood Glucose Market Projected to Reach $9.76 Billion by 2028, as Reported in Latest Research

By News RoomJanuary 24, 20243 Mins Read
United States Self-Monitoring Blood Glucose Market Projected to Reach .76 Billion by 2028, as Reported in Latest Research
Share
Facebook Twitter LinkedIn Pinterest Email
United States Self-Monitoring Blood Glucose Market Projected to Reach .76 Billion by 2028, as Reported in Latest Research

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) — The “United States Self-Monitoring Blood Glucose Market Size & Share Analysis – Growth Trends & Forecasts (2023 – 2028)” report has been added to ResearchAndMarkets.com’s offering.

The United States Self-Monitoring Blood Glucose Market analysis is demonstrating significant growth trends, with a forecast of expanding from USD 7.16 billion in 2023 to USD 9.76 billion by 2028. A compound annual growth rate (CAGR) of 6.40% is expected during the period from 2023-2028. This growth trajectory is attributed to several factors, including technological innovations, increased prevalence of diabetes, and rising awareness of the importance of glycaemic control.

Amidst rising obesity rates and associated diabetes challenges, the U.S. market shows a magnified focus on self-monitoring of blood glucose levels. The disruptive impact of the COVID-19 pandemic has further emphasized the necessity for efficient diabetes management, fostering advancements in remote monitoring and telemedicine services. This alignment of health technology with blood glucose management signifies a paradigm shift in diabetic care.

The Test Strips Segment—The Dominant Force in the Market
In a detailed segment evaluation, test strips have emerged as the dominant force, claiming about 80% of the market share. The dependence on these disposable and integral components of blood glucose testing perpetuates continuous growth within this segment. The frequency at which test strips are utilized compared to the relatively less frequent replacement of glucometers drives a consistent market pace, with the prevalence of reimbursement policies like those of Medicare abetting this trend.

Market Dynamics – A Glimpse into Rising Diabetes Prevalence
With over 130 million adults in the United States either diabetic or prediabetic, according to CDC data, the urgency for reliable self-monitoring of blood glucose is clear. The diabetes epidemic is disproportionally affecting communities characterized by lower income and educational levels, further emphasizing the need for accessible self-monitoring solutions.

The spurt in innovative technologies that synergize glucose monitoring with management platforms holds the potential to revolutionize diabetic care. Such holistic solutions are designed to empower patients in the management of diabetes, offering precise monitoring and collaborative care possibilities.

  • Technological Advancements: Digital health applications consolidating blood glucose readings and facilitating self-care are among the key drivers of the market.
  • Inclusive Policies: Resolutions aimed at enhancing diabetes prevention and management are propelling the growth of self-monitoring solutions.

Industry Overlook and Competitive Landscape

The United States self-monitoring blood glucose market is moderately fragmented, with significant players occupying a leading market share. These established entities are integral to the industry’s progress, contributing to developing and innovating blood glucose monitoring products and technologies that cater to diverse patient needs.

Strategic Alliances and Market Expansion
In response to the growing market demand, key players are actively engaging in strategic partnerships, mergers, and expansions to strengthen their market presence and address the evolving needs of diabetic care.

This expansive analysis delineates the current market scenario and the transformative strategies that are expected to shape the future of diabetes management in the United States, a critical public health concern.

A selection of companies mentioned in this report includes

  • Abbott Diabetes Care
  • Roche Holding AG
  • LifeScan
  • Trividia Health
  • Ascensia Diabetes Care
  • Acon Laboratories Inc.
  • Agamatrix Inc.
  • Bionime Corporation
  • Rossmax International Ltd.
  • Arkray Inc.

For more information about this report visit https://www.researchandmarkets.com/r/86bmr4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • United States Self Monitoring Blood Glucose Market United States Self Monitoring Blood Glucose Market Volume C A G R By Component 2023 2028

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Bitget lists VOOI (VOOI) for Spot Trading

Faraday Future Plan to Complete FF 91 2.0 Delivery and Transaction Process with ZEVO CEO Hebron Sher on December 22, with a Delivery Ceremony in January 2026

Wreaths Across America Presents the 2025 Founder’s Award Posthumously to Veteran and Volunteer Patrick Palmersheim of Iowa

CT3 reaches the final phase of beta testing for its next-generation decentralised storage system

Urbanica Debuts Next Generation Standing Desks Inspired by Movement Science for Improved Daily Energy and Focus

Remote Tank Monitoring (RTM) Market Outlook 2025-2029: Otodata and Anova Dominate Globally with Acquisitions and Innovation

FlareFlow Adds Blockbuster Titles to COL Group International’s Microdrama Licensing Catalogue

Paradox Vancouver Presents “Midnight Unmasked”

AOI Introduces New Ultra High-Power Semiconductor Laser to Support Silicon Photonics and CPO

Editors Picks

Bitget lists VOOI (VOOI) for Spot Trading

December 18, 2025

Former Saskatoon principal Duff Friesen gets six-month conditional sentence

December 18, 2025

Faraday Future Plan to Complete FF 91 2.0 Delivery and Transaction Process with ZEVO CEO Hebron Sher on December 22, with a Delivery Ceremony in January 2026

December 18, 2025

Google’s Gemini app can check videos to see if they were made with Google AI

December 18, 2025

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Saskatchewan digs out after significant Wednesday night snowfall

December 18, 2025

TikTok ban: all the news on the app’s shutdown and return in the US

December 18, 2025

Wreaths Across America Presents the 2025 Founder’s Award Posthumously to Veteran and Volunteer Patrick Palmersheim of Iowa

December 18, 2025
Facebook X (Twitter) Pinterest TikTok Instagram
© 2025 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version